The RIO study will see whether immune-based therapy (called bNAbs) can be used to treat HIV. These long-acting drugs will be given by infusion and be used instead of oral meds.

The study will be open to people who started HIV treatment soon after they became HIV positive.

More information will be added to this page after the study is fully approved.

Enrolment is hoped to start later in 2020, but will depend on how COVID-19 is affecting the UK.